- Home >
- About Us
|Registered Add||4～6th Floor, Talent Building E, No. 10 Xinghuo Rd, New & High-tech Development Zone, Nanjing, Jiangsu, China|
|Type of business||Manufacturer Of lnstruments and Reagents|
|Main Market||Biomedical In Vitro Diagnostic lnstruments and Reagents|
|Number of Employees||Over 500|
|Annual sales||100 milliom usd dollars|
- Nanjing Norman Biological Co.,Ltd
- Product Video
Nanjing Norman Biological Technology Co., Ltd is dedicated to R&D and manufacturing of Fluorescence immunoassay analyzer (FIA) and automated chemiluminescence system (CLIA). Founded in 2008, Norman biological has been upholding the idea that R&D shapes future ,and concentration determines success. Ever since the beginning, Norman has been focusing on developing and manufacturing FIA and CLIA instruments and reagents.
Norman's manufacture center is located in the Yuhua District and owns an over 2,000m2 GMP-approved clean workshop. The R&D base, which is over 2,000m2 , is located in state-level new Jiangbei district. Now there are over 100 R&D engineers, 40% of which hold a PhD or master's degree.
Powered by advanced technology and excellent talents in the IVD field, Norman has been consistently improving its innovation platform , and increasing R&D investment. Self-innovation, combined with long-term strategic cooperation with universities and research institutes and with outsourced technologies, ensures consistent improvement on product quality. Norman's R&D field has covered instruments, reagents, and raw materials, and has been entrusted by the Nanjing government to build a R&D center specialized in biological chemistry and immunity diagnosis. Up to now, Norman has acquired over 20 patents.
Being an expert in Immunofluorescence and automated chemiluminescence analysis , Norman owns independent and completed intellectual property rights, and its products provide top-notch sensitivity, precision and accuracy . Thanks to the self-developed antigens and self-manufactured antibodies, Norman's products features minimized intra-and inter- batch difference.
Norman is now on the fast track. An over 30,000m2 global R&D center is in construction, and will hold more than 1,000 R&D engineers in the future.
R&D shapes future, and concentration determines success. Driven by the commitment to "provide complete solution to improve human health", Norman will consistently do its utmost to drive the IVD industry forward and contribute more to human health.